#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uterine leiomyosarcoma Paraganglion neoplasm Acute on chronic liver failure Niemann-Pick disease Neonatal alloimmune thrombocytopenia Lip and/or oral cavity cancer Haemophilia A with anti factor VIII Neuroendocrine tumour of the lung Acquired C1 inhibitor deficiency Cutaneous T-cell lymphoma stage I Cystic fibrosis gastrointestinal disease Porphyria non-acute Primary immunodeficiency syndrome Bone marrow disorder Hypochondroplasia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Treatment Osteosarcoma – Basic Information Haemophilia B with anti factor IX – Trials in Disease Leiomyosarcoma – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Factor VIII deficiency – Trials in Disease Skin angiosarcoma – Trials in Disease Gastrointestinal stromal tumour – Basic Information Glycogen storage disease type II – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regtivex Bupropion Hydrochloride Sapropterin Dihydrochloride Io102 Hydrochloride Maraviroc Bio89-100 Jk08 Sildenafil Citrate Cefoxitin Digoxin Cholesterol Riboflavin Sodium Phosphate PALAZESTRANT THEOPHYLLINE ANHYDROUS Leniolisib Phosphate Oxacillin Masitinib Mannitol Siponimod Efepoetin Alfa More therapies…

    Learn about Your Condition

    Pancreatitis relapsing Spina bifida Bladder cancer stage II Vaginal cancer Thymoma Alveolar rhabdomyosarcoma Myeloproliferative neoplasm Skin cancer Vascular calcification Cholestatic pruritus Iron deficiency anaemia Erdheim-Chester disease Mantle cell lymphoma stage III Streptococcal infection Cryoglobulinaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • A study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Croatia Hungary Poland Portugal Slovakia Spain

  • Using glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Glucagon
    • Dasiglucagon
    Denmark

  • A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Palopegteriparatide
    France Germany Poland Romania

  • Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Glimepiride
    Denmark

  • A Study of Atumelnant for Children with Congenital Adrenal Hyperplasia

    Recruiting

    4 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • ATUMELNANT
    Belgium France Germany Italy The Netherlands Poland

  • A study of estradiol and progesterone treatment for blood sugar control in women with type 1 or type 2 diabetes during or after menopause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopause
    • Diabetes mellitus
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands
1 2 3 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!